Annexin A5
Showing 1 - 25 of >10,000
Healthy Trial in Groningen (ANXV, Placebo)
Completed
- Healthy
- ANXV
- Placebo
-
Groningen, NetherlandsQPS Netherlands B.V.
May 12, 2022
Sepsis Trial in Nanjing (SY-005, Placebo)
Recruiting
- Sepsis
- SY-005
- Placebo
-
Nanjing, Jiangsu, ChinaZhongda Hospital，Affiliated to Southeast University
Feb 27, 2022
Coronavirus Infection, Sepsis Trial in London (recombinant human annexin A5, Placebo)
Recruiting
- Coronavirus Infection
- Sepsis
- recombinant human annexin A5
- Placebo
-
London, Ontario, CanadaLondon Health Sciences Centre
Apr 23, 2021
Retinal Vein Occlusion Trial in Groningen (Annexin A5)
Recruiting
- Retinal Vein Occlusion
- Annexin A5
-
Groningen, NetherlandsUMCG
Nov 11, 2021
GCF Annexin-A1, Carbonic Anhydrase-1, and Elongation Factor-1
Completed
- Periodontitis
- Periodontal Inflammation
- Peirodontal clinical measurements and gingival crevicular fluid sampling
-
İzmir, TurkeyDokuz Eylul University, Faculty of Dentistry, Department of Peri
Jan 10, 2023
Clinical Significance of Anti-annexin A2 Antibodies in COVID-19
Recruiting
- COVID-19
-
Amiens, FranceCHU Amiens
Feb 17, 2022
Annexin A1 Levels in SARS-CoV-2 Infection
Completed
- Annexin A1
- Adrenal Cortex Hormones
- Blood serum samples
-
Kars, Outside Of The US, TurkeyRamazan Sabirli
Jun 29, 2021
Endocarditis, Thrombosis Trial in Paris (99mTc-Annexin V-128 SPECT)
Terminated
- Endocarditis
- Thrombosis
- 99mTc-Annexin V-128 SPECT
-
Paris, FranceBichat Hospital
Aug 25, 2021
Carotid Atherosclerosis, Atherosclerotic Plaque Trial (99mTc-Annexin-V-128 uptake on scintigraphy)
Withdrawn
- Carotid Atherosclerosis
- Atherosclerotic Plaque
- 99mTc-Annexin-V-128 uptake on scintigraphy
- (no location specified)
Oct 15, 2021
Systemic Lupus Erythematosus (SLE), Lupus Nephritis Trial in Amiens (ANXA2)
Completed
- Systemic Lupus Erythematosus (SLE)
- Lupus Nephritis
- ANXA2
-
Amiens, FranceCHU Amiens
Jul 17, 2020
Cholecystitis; Gallstone, Cholecystolithiasis, Cholecystitis, Chronic Trial in Aswan (5-5-5-8 technique, 10-10-10-5 technique)
Recruiting
- Cholecystitis; Gallstone
- +2 more
- 5-5-5-8 technique
- 10-10-10-5 technique
-
Aswan, EgyptAswan University Hospital
Sep 20, 2023
Alport Syndrome Trial in Shanghai (Ramipril)
Not yet recruiting
- Alport Syndrome
-
Shanghai, ChinaXinhua Hospital, Shanghai Jiao Tong University School of Medicin
Nov 23, 2021
Female Sexual Arousal Disorder, Female Sexual Dysfunction Trial (BZ371A 7.5 mg (1.5 ml), BZ371A 5.0 mg (1.0 ml), BZ371A 2.5 mg
Not yet recruiting
- Female Sexual Arousal Disorder
- Female Sexual Dysfunction
- BZ371A 7.5 mg (1.5 ml)
- +5 more
- (no location specified)
Oct 30, 2023
Rabies Vaccine Adverse Reaction Trial in Changsha (Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose
Completed
- Rabies Vaccine Adverse Reaction
- Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose program
- +3 more
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 9, 2023
Chewing Problem, Mastication Disorder Trial in L'Hospitalet De Llobregat (F, R, L)
Completed
- Chewing Problem
- Mastication Disorder
- F
- +5 more
-
L'Hospitalet De Llobregat, Catalonia, SpainSchool of Dentistry, University of Barcelona
May 24, 2022
Actinic Keratoses Trial (Cream containing madecassoside and 5 % panthenol, Daylight PDT)
Not yet recruiting
- Actinic Keratoses
- Cream containing madecassoside and 5 % panthenol
- Daylight PDT
- (no location specified)
Jul 6, 2023
Cementless Triathlon 5YR Follow-Up
Not yet recruiting
- Knee Arthroplasty, Total
- +2 more
- Cementless Total Knee Replacement
-
London, Ontario, CanadaUniversity Hospital
May 24, 2023
Colorectal Cancer Metastatic Trial in Adelaide (CNA3103: 5 x 10^7 cells, CNA3103: 1.5 x 10^8 cells, CNA3103: 4.5 x 10^8 cells)
Not yet recruiting
- Colorectal Cancer Metastatic
- CNA3103: 5 x 10^7 cells
- +4 more
-
Adelaide, South Australia, AustraliaCarina Biotech Investigators
Feb 26, 2023
Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)
Recruiting
- Relapse/Refractory Multiple Myeloma
- DeepTag-GPRC5D Targeted CAR T-cells
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023
Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)
Not yet recruiting
- Influenza, Human
- FLU Q-PAN H5N8 Formulation 1
- +3 more
- (no location specified)
Jul 27, 2023
COVID-19 Trial in Wuhan (Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For
Recruiting
- COVID-19
- Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jun 1, 2023
To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast
Active, not recruiting
- To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast Cancer After 5 Years
- OFS continues to use group after 5 years
- Immunohistochemical detection of HR status
-
Wuhan, Hubei, ChinaWu Xinhong
Sep 17, 2023
Autophagy/Apoptosis Balance During Pregnancy
Recruiting
- Pregnancy Related
- Blood test
-
Nîmes, FranceCHU de Nimes
Sep 20, 2022
Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis
Completed
- Endometriosis
- endometriosis surgery
- other benign condition surgeries
-
Istanbul, Bagcilar, TurkeyBagcilar Teaching and Research Hospital
Mar 26, 2022